First Wave BioPharma Inc.

NASDAQ: FWBI · Real-Time Price · USD
2.96
0.13 (4.59%)
At close: May 16, 2024, 10:00 PM

First Wave BioPharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a 29.27K 106.21K 537.4K
Gross Profit
n/a -29.27K -106.21K -537.4K
Operating Income
-15.62M -15.77M -12.68M -59.06M
Interest Income
n/a 19.93K 8.41K 1.17K
Pretax Income
-18.06M -15.79M -14.63M -58.54M
Net Income
-18.06M -15.79M -16.58M -59.08M
Selling & General & Admin
14.72M 10.71M 11.99M 18.38M
Research & Development
903.94K 5.03M 691.26K 38.32M
Other Expenses
n/a n/a n/a 529.1K
Operating Expenses
15.62M 15.74M 12.68M 56.7M
Interest Expense
875.00 22.46K 15.88K 11.23K
Selling & Marketing Expenses
n/a -29.27K n/a n/a
Cost & Expenses
n/a 15.77M 12.68M 56.7M
Income Tax Expense
n/a -4 1.95M 540.34K
Shares Outstanding (Basic)
3.43M 336.34K 35.91K 2.13K
Shares Outstanding (Diluted)
3.43M 336.34K 35.91K 2.13K
EPS (Basic)
-5.33 -46.96 -461.72 -27.8K
EPS (Diluted)
-5.33 -46.96 -461.72 -27.8K
EBITDA
-15.62M -15.74M -12.87M -55.63M
EBIT
n/a -15.82M -14.61M -56.17M
Depreciation & Amortization
n/a 29.27K -195.06K 3.42M